Progress in Vaccinology
Vaccines have historically been considered to be the most cost-effective method for preventing communicable diseases. It was a vaccine that en abled global eradication of the dreaded disease smallpo.
Main Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
New York, NY
Springer New York
1989, 1989
|
Edition: | 1st ed. 1989 |
Series: | Progress in Vaccinology
|
Subjects: | |
Online Access: | |
Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- I Opening Remarks
- 1. Vaccinology: The Two Revolutions
- II Public Health Perspective—The Present Scene
- 2. Vaccinology and the Goal of Health for All
- 3. Toward Universal Immunization: 1990
- 4. New and Improved Techniques for Vaccine Production
- 5. Transfer of Vaccine Production to the Developing World: Rabies Vaccine
- 6. Policy for Developing Countries for Storage, Distribution, and Use of Essential Vaccines for Immunoprophylaxis
- III Environmental Factors Modulating The Efficacy of The Vaccine
- 7. Immunity in Tuberculosis: Environmental Versus Intrinsic Factors Modulating the Immune Responsiveness to Mycobacteria
- 8. Geographic Variation in Vaccine Efficacy: The Polio Experience
- IV Hepatitis
- 9. Molecular Immunology of Viral Antigens in Hepatitis B Vaccinations
- 10. Biologic Significance of Pre-S Antigen and Anti-Pre-S Antibodies in Hepatitis B Virus Infection
- 11. Enterically Transmitted Hepatitis Viruses: Prospects for Control
- VI Filariasis
- 24. Importance of Antibody Class in Helminth Infections
- 25. Immunodiagnosis of Filariasis
- VII Veterinary Vaccines
- 26. Development, Production, and Application of Vaccines in Foot-and-Mouth Disease Control in India
- 27. Cell Culture Vaccine Against Bovine Tropical Theileriosis
- VIII Leprosy
- 28. Present Approaches to Immunotherapy and Immunoprophylaxis for Leprosy
- 29. Armadillo-Derived Killed M. leprae: Candidate Vaccine Against Leprosy
- 30. Mycobacterium w: Candidate Vaccine Against Leprosy with Antigens Cross-Reactive with Three Major Protein Antigens of Mycobacterium leprae
- 31. Molecular Approaches to Developing a Vaccine for Leprosy,
- 32. Immunodiagnosis of Leprosy
- 33. Immunodiagnostic Approaches to the Detection of M. leprae Infection in Leprosy
- 34. Serological Survey of Leprosy Using a Monoclonal Antibody-Based Immunoassay and Phenolic Glycolipid ELISA
- IX Malaria and Leishmaniasis
- 12. Immunological Characterization of a Viral Agent Involved in Epidemic and Sporadic Non-A Non-B Hepatitis
- V Gastrointestinal Infections
- 13. Attenuated Oral Typhoid Vaccine Ty 21a
- 14. Oral B Subunit—Whole Cell Vaccine Against Cholera: From Basic Research to Successful Field Trial
- 15. Prospects of Immunization Against Cholera by Adhesive Antigen
- 16. Protective Antigens of Vibrio cholerae
- 17. Rationale for the Development of a Rotavirus Vaccine for Infants and Young Children
- 18. Mucosal Immunity in the Gastrointestinal Tract in Relation to ETEC Vaccine Development
- 19. Shigella Vaccines
- 20. DNA Sequence Homology Among Genes of Shigella spp. and Enteroinvasive Escherichia coli..
- 21. Mucosal and Acquired Immunity in Giardiasis and Its Relation to Diarrhea and Malabsorption
- 22. Immunology of Entamoebahistolytica in Human and Experimental Hosts
- 23. Molecular Comparisons Among Entamoeba histolytica Strains Using DNA and Protein Profiles
- 35. Antisporozoite Malaria Vaccine Development Based on Circumsporozoite Protein
- 36. Malaria Sporozoite Vaccine Development: Recent Progress
- 37. Community-Based Integrated Vector Control of Malaria in India
- 38. Leishmaniasis and Malaria: New Tools for Epidemiological Analysis
- X New Approaches to Vaccinology
- 39. Vaccinia Virus Expression Vectors
- 40. Vaccinia Recombinants Expressing Foreign Antigens: Antiviral and Antitumor Immunity
- 41. Liposomes as Carriers of Vaccines
- 42. A Short Primer on Vaccine Design: Focus on the Interrelatedness of Antigenic Determinants Addressing Various Lymphocyte Sub-populations
- 43. Next Steps in the Evolution of Vaccinology